Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy
Who is this study for? Patients undergoing vitrectomy
What treatments are being studied? NPI-002
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Indicated for vitrectomy
• Natural Lens in place at time of vitrectomy
• Some cataract present as assessed pre-operatively
Locations
Other Locations
Australia
Royal Adelaide Hospital
RECRUITING
Adelaide
Contact Information
Primary
Jami R Kern, PhD
jami@nacuity.com
817-291-4232
Time Frame
Start Date: 2022-01-27
Estimated Completion Date: 2025-12
Participants
Target number of participants: 30
Treatments
Experimental: Single NPI-002 Intravitreal Implant
one NPI-002 implant inserted at the time of vitrectomy
Experimental: Double NPI-002 Intravitreal Implant
two NPI-002 implants inserted at the time of vitrectomy
No_intervention: Control
No implant inserted at time of vitrectomy
Related Therapeutic Areas
Sponsors
Leads: Nacuity Pharmaceuticals, Inc.